Sowell Financial Services’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-115
Closed -$7K 1447
2021
Q1
$7K Sell
115
-21
-15% -$2.6K ﹤0.01% 2461
2020
Q4
$16K Sell
136
-840
-86% -$90.4K ﹤0.01% 1831
2020
Q3
$85K Sell
976
-394
-29% -$34.4K ﹤0.01% 1029
2020
Q2
$123K Buy
+1,370
New +$138K 0.01% 900

Other funds holding HAE

Sowell Financial Services's HAE Position: Q2 2021 in Review

Sowell Financial Services sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 115 shares — an estimated $7K sold.

Sowell Financial Services first reported a position in HAE in Q2 2020 and held it in 4 quarters. The position peaked at $123K in Q2 2020. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

  • Sowell Financial Services reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 115 Haemonetics shares in Q2 2021, an estimated $7K.
  • Sowell Financial Services first reported a position in Haemonetics in Q2 2020 and held it in 4 quarters.
  • Sowell Financial Services's Haemonetics position peaked at $123K in Q2 2020.
  • 258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.